Skip to main content

Advertisement

SpringerLink
Log in

May increased CA125 in borderline ovarian tumor be indicative of a poor prognosis? A case report

  • Research Article
  • Published:
Tumor Biology

Abstract

We present a case of a 58-year-old menopausal woman referred to our hospital for the presence of large pelvic masses diagnosed by clinical examination and pelvic ultrasound. MRI examination showed voluminous bilateral capsulated multilocular ovarian cysts slightly hyperintense on T1-weighted images with thick septa and small papillary projections. CT scan confirmed the MRI findings. Among the ovarian tumor markers analyzed (CA125, HE4, and CA72.4), only Ca125 was slightly increased (48 U/ml). These data were suggestive of mucinous ovarian tumor. The patient underwent total hysterectomy with bilateral salpingo-oophorectomy, appendectomy, and multiple peritoneal biopsies. Pathological examination revealed bilateral borderline mucinous ovarian tumor with superficial atypical implants. Nine months later, the patient complained of left coxofemoral pain and underwent a PET/TC total body that suggested pubic bone metastases. Ovarian tumor markers were analyzed, and a second PET/TC was performed. CA125 was 252 U/ml, HE4 62 pM/L, and CA72.4 > 100 U/Ml. PET/TC was suggestive of peritoneal carcinosis. The patient was readmitted to the hospital. Clinical examination revealed small vaginal nodules. All nodules were excised. Microscopic analysis of all specimens revealed metastatic mucinous adenocarcinoma of intestinal type.

The case shows that even a slight CA125 increase in the presence of a borderline ovarian tumor should not be overlooked since it can be indicative of a progressive disease. This case also highlights its additional diagnostic value when serum CA125 analysis is used in conjunction with MRI and CT imaging for the prognosis of mucinous borderline ovarian tumors (mBOTs).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig 1
Fig 2
Fig 3

Similar content being viewed by others

References

  1. Messalli EM, Grauso F, Balbi G, Napolitano A, Seguino E, Torella M. Borderline ovarian tumors: features and controversial aspects. Eur J Obstet Gynecol Reprod Biol. 2013;167(1):86–9.

    Article  PubMed  Google Scholar 

  2. Acs G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am J Clin Pathol. 2005;123:S13–57.

    PubMed  Google Scholar 

  3. Midulla C, Manganaro L, Longo F, Viggiani V, Frati L, Granato T, et al. HE4 combined with MDCT imaging is a good marker in the evaluation of disease extension in advanced epithelial ovarian carcinoma. Tumor Biol. 2012;33(5):1291–8.

    Article  CAS  Google Scholar 

  4. 4) Burkholz K J, Wood B P, Zuppan C. RadioGraphics: borderline papillary serous tumor of the right ovary. 2005; 25: 1689–1692

  5. Cusido M, Balaguero L, Hernandez G, Falcon O, Rodriguez-Escudero FJ, Vargas JA, et al. Results of the national survey of borderline ovarian tumors in Spain. Gynecol Oncol. 2007;104:617–22.

    Article  PubMed  Google Scholar 

  6. Anastasi E, Granato T, Falzarano R, Storelli P, Ticino A, Frati L, et al. The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer. J Ovarian Res. 2013;6(1):44.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Marcus CS, Maxwell GL, Darcy KM, Hamilton CA, McGuire WP. Current approaches and challenges in managing and monitoring treatment response in ovarian cancer. J Cancer. 2014;5(1):25–30.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Molecular Medicine, Sapienza University of Rome, Policlinico Umberto I, Viale Regina Elena 324, 00161, Rome, Italy

    Emanuela Anastasi & Luigi Frati

  2. Department of Gynecology, Obstetrics and Urology, Sapienza University of Rome, Policlinico Umberto I, Viale del Policlinico 155, 00161, Rome, Italy

    Maria Grazia Porpora & Pierluigi Benedetti Panici

  3. Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Policlinico Umberto I, Viale Regina Elena 324, 00161, Rome, Italy

    Irene Pecorella, Silvia Bernardo & Lucia Manganaro

Authors
  1. Emanuela Anastasi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Grazia Porpora
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Irene Pecorella
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Silvia Bernardo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Luigi Frati
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pierluigi Benedetti Panici
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lucia Manganaro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emanuela Anastasi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anastasi, E., Porpora, M.G., Pecorella, I. et al. May increased CA125 in borderline ovarian tumor be indicative of a poor prognosis? A case report. Tumor Biol. 35, 6969–6971 (2014). https://doi.org/10.1007/s13277-014-1898-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-1898-9

Keywords

Search

Navigation